Market Overview - U.S. stocks experienced significant gains in Q3 2025, with the Nasdaq Composite, S&P 500, and Dow Jones Industrial Average rising by 11.2%, 7.8%, and 5.2% respectively [1] - The growth was fueled by expectations of further Federal Reserve rate cuts, strong Q2 earnings, and optimism surrounding artificial intelligence (AI) [2] Recommended Growth Stocks - Five growth stocks are recommended for Q4 2025: Micron Technology Inc. (MU), Workday Inc. (WDAY), Exact Sciences Corp. (EXAS), Evercore Inc. (EVR), and Coeur Mining Inc. (CDE) [2] - These stocks exhibit strong revenue and earnings growth potential, with positive earnings estimate revisions in the past 30 days [3] Micron Technology Inc. (MU) - Micron is a leader in the AI infrastructure boom, driven by high demand for its high-bandwidth memory (HBM) solutions and record sales in the data center market [6][9] - The company is capitalizing on the growing adoption of AI servers, which require more memory than traditional servers, boosting demand for DRAM [7] - Micron's expected revenue and earnings growth rates are 42.4% and over 100% respectively for the current year, with a 27% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [10] Workday Inc. (WDAY) - Workday's diversified product portfolio and cloud-based business model are key growth drivers, with strong customer traction in international markets [11] - Significant investment from Elliott Investment Management is expected to enhance innovation, particularly in AI and machine learning [12] - Workday's expected revenue and earnings growth rates are 12.6% and 21.1% respectively for the current year, with a 0.3% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [13] Exact Sciences Corp. (EXAS) - Exact Sciences benefits from strong adoption of its Cologuard product, with the recent introduction of Cologuard Plus gaining Medicare coverage [14] - The launch of Oncodetect has advanced MRD testing, with secured Medicare reimbursement opening access for cancer patients [15] - Exact Sciences has an expected revenue and earnings growth rate of 14.4% and over 100% respectively for the current year, with a 9.1% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [16] Evercore Inc. (EVR) - Evercore is expanding its advisory client base and diversifying revenue sources, which is expected to support top-line growth [17] - The company has a strong liquidity position, allowing for capital distribution through dividend hikes and share repurchase programs [17] - Evercore's expected revenue and earnings growth rates are 17.4% and 34.4% respectively for the current year, with a 2.1% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [18] Coeur Mining Inc. (CDE) - Coeur Mining operates as a primary silver and gold producer with mines in the Americas, including properties in Mexico, Bolivia, Nevada, and Alaska [19] - The company has an expected revenue and earnings growth rate of 88.3% and over 100% respectively for the current year, with a 3.8% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [20]